Effects of empagliflozin in patients with heart failure and preserved ejection fraction according to baseline diuretic use: results from the EMPEROR-Preserved trial
26 August 2022 (08:00 - 19:30)
Organised by:
About the speaker
Baylor Scott & White Health, Dallas (United States of America)
4 More presentations in this session
Mr A. van de Bovenkamp (Amsterdam, NL)
Associate Professor R. Wachter (Leipzig, DE)
Doctor G. Salama (Pittsburgh, US)
Access the full session
The Event
ESC Congress 2022
26 August - 29 August 2022
You may be interested in
Congress Presentation
